berberine has been researched along with atorvastatin in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Chi, L; Hu, X; Pan, N; Peng, L; Zhang, Y | 2 |
| Fang, L; Fang, Q; Feng, P; Guo, F; Li, B; Liang, Z; Xu, X; Zhan, G; Zhang, B; Zhao, L | 1 |
| Cai, Y; Chen, C; Hu, Z; Li, C; Liu, X; Liu, Y; Luo, H; Wang, DZ; Wu, G; Xia, X; Xu, Z; Yang, Y; Yu, J; Zeng, C; Zhang, W; Zhang, X | 1 |
5 other study(ies) available for berberine and atorvastatin
| Article | Year |
|---|---|
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Berberine combined with atorvastatin downregulates LOX‑1 expression through the ET‑1 receptor in monocyte/macrophages.
Topics: Animals; Anticholesteremic Agents; Atherosclerosis; Atorvastatin; Berberine; Body Weight; Cells, Cultured; Cholesterol; Diet, High-Fat; Dietary Fats; Dose-Response Relationship, Drug; Drug Synergism; Gene Expression Regulation; Heptanoic Acids; Macrophages; Male; Pyrroles; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; RNA, Small Interfering; Scavenger Receptors, Class E; Signal Transduction; Triglycerides | 2014 |
The anti-atherogenic effects of berberine on foam cell formation are mediated through the upregulation of sirtuin 1.
Topics: Adenylate Kinase; Atherosclerosis; Atorvastatin; Berberine; Cholesterol; Foam Cells; Heptanoic Acids; Humans; Lipoproteins, LDL; Macrophages; PPAR gamma; Pyrroles; Sirtuin 1; Up-Regulation | 2014 |
The enhancement of cardiotoxicity that results from inhibiton of CYP 3A4 activity and hERG channel by berberine in combination with statins.
Topics: Action Potentials; Animals; Atorvastatin; Berberine; Cytochrome P-450 CYP3A; ERG1 Potassium Channel; Gene Expression; HEK293 Cells; Hep G2 Cells; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kinetics; Long QT Syndrome; Microsomes, Liver; Rats; Simvastatin; Testosterone | 2018 |
Regulation of Cholesterol Homeostasis by a Novel Long Non-coding RNA LASER.
Topics: Anticholesteremic Agents; Apolipoproteins; Atorvastatin; Benzoates; Benzylamines; Berberine; Cholesterol; Chromosomes, Human, Pair 11; Coronary Disease; Gene Expression Regulation; Genome-Wide Association Study; Hep G2 Cells; Hepatocyte Nuclear Factor 1-alpha; Hepatocytes; Histone Code; Histone Demethylases; Homeostasis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Leukocytes, Mononuclear; Proprotein Convertase 9; Protein Binding; Protein Interaction Mapping; RNA Interference; RNA, Long Noncoding; RNA, Small Interfering | 2019 |